Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Baxter
US Army
Covington
Boehringer Ingelheim
Express Scripts

Generated: April 22, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Beloranib

« Back to Dashboard

US Patents for Beloranib

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Beloranib ➤ Sign Up Methods of treating a subject with benign prostate hyperplasia Zafgen, Inc. (Cambridge, MA) ➤ Sign Up
Beloranib ➤ Sign Up Fumigillol compounds and methods of making and using same Zafgen, Inc. (Boston, MA) ➤ Sign Up
Beloranib ➤ Sign Up Fumagillol heterocyclic compounds and methods of making and using same Zafgen, Inc. (Boston, MA) ➤ Sign Up
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
AstraZeneca
McKinsey
Chinese Patent Office
Cantor Fitzgerald
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.